Gender | Age | Menopause | Menopause Absent
Item
1. women of more than 18 years old (menopause or not).
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0025320 (UMLS CUI [3])
C0025320 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
Gender | Invasive carcinoma of breast metastatic | Invasive carcinoma of breast | Tamoxifen | Aromatase Inhibitors
Item
2. women with invasive breast cancer metastatic or non-metastatic, for which treatment with tamoxifen or anti-aromatase is retained.
boolean
C0079399 (UMLS CUI [1])
C0853879 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
C0853879 (UMLS CUI [3])
C0039286 (UMLS CUI [4])
C0593802 (UMLS CUI [5])
Cancer Hormone Expression Estrogen Receptor | Cancer Hormone Expression Progesterone Receptor | Tumor Cells Percentage Immunohistochemistry
Item
3. cancer hormone-expressing estrogen receptor (er) and / or progesterone receptor (pr) (≥ 10% of tumor cells in technical hic).
boolean
C0006826 (UMLS CUI [1,1])
C0019932 (UMLS CUI [1,2])
C0017262 (UMLS CUI [1,3])
C0034804 (UMLS CUI [1,4])
C0006826 (UMLS CUI [2,1])
C0019932 (UMLS CUI [2,2])
C0017262 (UMLS CUI [2,3])
C0034833 (UMLS CUI [2,4])
C0597032 (UMLS CUI [3,1])
C0439165 (UMLS CUI [3,2])
C0021044 (UMLS CUI [3,3])
Hormone Therapy To be stopped
Item
4. any previous hormonal therapy, stopped for progression, should be discontinued for at least 21 days prior to study entry.
boolean
C0279025 (UMLS CUI [1,1])
C1272691 (UMLS CUI [1,2])
WHO performance status scale
Item
5. who ≤ 2.
boolean
C1298650 (UMLS CUI [1])
Childbearing Potential Contraceptive methods
Item
6. women of childbearing age must use effective contraception for the duration of the study.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Informed Consent
Item
7. informed consent obtained and signed before any specific procedure in the study.
boolean
C0021430 (UMLS CUI [1])
Patient Member National Health Insurance
Item
8. patient member in a national insurance scheme.
boolean
C0030705 (UMLS CUI [1,1])
C0680022 (UMLS CUI [1,2])
C0027452 (UMLS CUI [1,3])
HER2-positive carcinoma of breast Immunohistochemistry | HER2-positive carcinoma of breast FISH | HER2-positive carcinoma of breast CISH
Item
1. patient with breast cancer her2 positive (ihc and / or fish-cish)
boolean
C1960398 (UMLS CUI [1,1])
C0021044 (UMLS CUI [1,2])
C1960398 (UMLS CUI [2,1])
C0162789 (UMLS CUI [2,2])
C1960398 (UMLS CUI [3,1])
C1516514 (UMLS CUI [3,2])
Hormone Therapy Pre-existing | Discontinuation Hormone Therapy Lacking
Item
2. patient already receiving hormonal therapy or patient who has not stopped hormonal therapy for at least 21 days.
boolean
C0279025 (UMLS CUI [1,1])
C2347662 (UMLS CUI [1,2])
C1444662 (UMLS CUI [2,1])
C0279025 (UMLS CUI [2,2])
C0332268 (UMLS CUI [2,3])
Chemotherapy Required Breast Carcinoma | Targeted Therapy Required Breast Carcinoma | Exception Hormone Therapy
Item
3. patient that should receive a chemotherapy and / or another targeted therapy (other than hormonal therapy) for the treatment of the breast cancer.
boolean
C0392920 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
C2985566 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0678222 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0279025 (UMLS CUI [3,2])
Medical condition Study Subject Participation Status Inappropriate | Mental condition Study Subject Participation Status Inappropriate | Laboratory test result abnormal Severe Study Subject Participation Status Inappropriate | Laboratory test result abnormal Study Subject Participation Status Inappropriate | Laboratory test result abnormal chronic Study Subject Participation Status Inappropriate
Item
4. any other medical or psychiatric condition or laboratory abnormality severe, acute or chronic making the inclusion of the patient in the study inappropriate in the opinion of the investigator.
boolean
C3843040 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C1548788 (UMLS CUI [1,3])
C3840291 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C1548788 (UMLS CUI [2,3])
C0438215 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C2348568 (UMLS CUI [3,3])
C1548788 (UMLS CUI [3,4])
C0438215 (UMLS CUI [4,1])
C2348568 (UMLS CUI [4,2])
C1548788 (UMLS CUI [4,3])
C0438215 (UMLS CUI [5,1])
C0205191 (UMLS CUI [5,2])
C2348568 (UMLS CUI [5,3])
C1548788 (UMLS CUI [5,4])
Protocol Compliance Unable
Item
5. patient unable to follow procedures, visits, examinations described in the study.
boolean
C0525058 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
6. pregnant women or nursing mothers can not participate in the study.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Patients Guardianship
Item
7. patients under legal guardianship.
boolean
C0030705 (UMLS CUI [1,1])
C0870627 (UMLS CUI [1,2])